3rd Jul 2017 14:18
| For Immediate Release | 3 July 2017 | 
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 Employee Share Option Scheme | |||
| Period of return: | From: | 1 January 2017 | To: | 30 June 2017 | 
| Balance of unallotted securities under scheme(s) from previous return: | 5,136,076 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | NIL | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 678,905 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 4,457,171 | |||
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 Long Term Incentive Plan | |||
| Period of return: | From: | 1 January 2017 | To: | 30 June 2017 | 
| Balance of unallotted securities under scheme(s) from previous return: | 20,964,226 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | NIL | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | NIL | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 20,964,226 | |||
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 Deferred Bonus Plan | |||
| Period of return: | From: | 1 January 2017 | To: | 30 June 2017 | 
| Balance of unallotted securities under scheme(s) from previous return: | NIL | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 10,000,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | NIL | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 10,000,000 | |||
| Name of contact: | Tim Watts | 
| Telephone number of contact: | 01865 783000 | 
Related Shares:
Oxford Biomedica